Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
750,229
-
Shares change
-
+171,301
-
Total reported value, excl. options
-
$19,572,000
-
Value change
-
+$4,481,033
-
Put/Call ratio
-
103%
-
Number of buys
-
14
-
Number of sells
-
-11
-
Price
-
$26.10
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q3 2016
34 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q3 2016.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 750,229 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (164,514 shares), RAYMOND JAMES & ASSOCIATES (148,567 shares), MORGAN STANLEY (91,245 shares), WELLS FARGO & COMPANY/MN (74,380 shares), GOLDMAN SACHS GROUP INC (50,036 shares), Virtu Financial LLC (35,486 shares), KCG Holdings, Inc. (33,821 shares), UBS Group AG (31,190 shares), LPL Financial LLC (30,279 shares), and Commonwealth Equity Services, Inc (15,623 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.